Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017
- GBI Research
- June 2017
- Healthcare IT
- 67 pages
GBI Research’s latest report Mobile Health (mHealth) Technologies: Global Market Prospects – Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries – including organizations that already implement mHealth solutions and services, and those that do not. The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI’s own analytical views to provide an assessment that is comprehensive in outlook.
mHealth is a branch of eHealth, and commonly defined as the use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers as well as policy markets. It can have a significant impact on consumers and on all aspects of the pharmaceutical and healthcare sector, and companies are making large investments to leverage these technologies more effectively. mHealth technologies are already a reality in both developed and developing countries, and their uptake is expected to significantly increase in the near future, particularly as the overall healthcare industry continues to shift towards value-based medicine, and due to the increasing need for more cost-effective means to deliver healthcare and to demonstrate the value and effectiveness of medical treatments.
The report features an overview of mHealth solutions and services and its place within the pharmaceutical industry. It examines the factors driving and necessitating the use of these technologies within this industry, and provides detailed examples of how different solutions could be used to provide direct benefits to pharmaceutical companies, healthcare institutions and patients. There is also an analysis of the main challenges surrounding these technologies, as well as case studies of how companies are already implementing mHealth, and deal with some of the challenges. Finally, based on the totality of the survey results and research, strategic recommendations are provided for the effective implementation of new mHealth initiatives.
The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including results from key geographical markets. The survey examined key issues, such the areas where pharmaceutical organizations are currently utilizing mHealth; where they believe it can have the most impact; the main barriers to uptake and driving factors; the likelihood of increasing investment within the next five years; and the overall attitude towards the use of these technologies within the pharmaceutical industry.
GBI Research conducted extensive research to provide a comprehensive view of mHealth solutions and services. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.
- What are mHealth technologies. What is their place within the pharmaceutical industry.
- How prevalent is the use of mHealth technologies in the pharmaceutical, healthcare and healthcare IT industries.
- What are the main driving factors necessitating the use of mHealth. What is the relative importance of these factors.
- What are the commercial benefits that the use of mHealth solutions and services can provide across the pharmaceutical value chain.
- In which areas are organizations currently using mHealth, and where do they feel it will have the most impact in the next five years.
- What are the main challenges associated with mHealth technologies. What is the relative importance of these factors across key geographical markets. For the organizations that do not yet utilize mHealth solutions, what specific reasons have led to this decision.
- What is the likelihood that organizations that already use mHealth will increase their investment within the next five years. Will those that do not currently invest in the technology begin doing so over this period.
- How can mHealth initiatives be effectively implemented within an organization.
- What is the overall opinion of industry experts on the use of mHealth technologies.
Reasons To Buy
- Gain insightful analyses and comprehensive understanding of mHealth technologies
- Understand the key drivers necessitating the use of mHealth and the main barriers to implementation
- Understand the views of 65 different organizations within the industry on mHealth
- Assess the most relevant uses of mHealth solutions and services within your company, and effective ways of implementing mHealth initiatives
Have query on this report?Make an Enquiry
Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 mHealth Technologies Overview 8
2.1 What are mHealth Technologies? 8
2.2 What Types of Services Can mHealth Technologies Provide? 9
2.3 What are the Main Objectives of mHealth Technologies? 9
2.4 Key Stakeholders Involved in the Funding and Provision of mHealth 10
2.5 Key Market Segments in the mHealth Market Space 12
2.5.1 Key Sub-segments of the Global mHealth Market 14
2.6 How Prevalent is the Use of mHealth Technologies by Healthcare Organizations? Results from Our Industry-Wide Survey 15
3 The Global mHealth Market: The Most Important Drivers and Restraints in 2017 18
3.1 What Are the Most Important Growth Drivers in the Global mHealth Market? – Results from our Industry-Wide Survey 18
3.1.1 Providing Cost-Effective Care to Patients through mHealth Solutions 19
3.1.2 Can the Value and Effectiveness of Treatments be Demonstrated through mHealth Solutions? 19
3.1.3 How Interested Are HCPs and Reimbursement Entities in mHealth? 20
3.1.4 Accelerated Penetration of Mobile Technology at a Global Level 20
3.1.5 mHealth Solutions Helping Pharma Companies Solve Gaps in R&D Productivity 20
3.1.6 Is Government Funding and Support for mHealth in Key Markets Making a Difference? 21
3.1.7 Other Important Growth Drivers in the mHealth Market in 2017 21
3.1.8 What Are the Most Important Growth Drivers in the mHealth Market by Region? Results from our Industry-Wide Survey 22
3.2 What Are the Main Restraints in the Global mHealth Market? Results from our Industry-Wide Survey 23
3.2.1 What Are the Main Data Security and Privacy Concerns that Currently Surround mHealth Technologies? 24
3.2.2 Need for Clear and Harmonized Regulatory Frameworks for mHealth 24
3.2.3 Reluctance of Healthcare Professionals in Adopting New Technologies 26
3.2.4 How Much Evidence is there Documenting the Benefits of mHealth Technologies? 26
3.2.5 Is there a Shortage of Skilled IT Professionals in the Healthcare Industry? 27
3.2.6 What Are the Particular Reasons Specific Organizations Have Not Invested in mHealth Initiatives? Results from our Industry-Wide Survey 27
4 mHealth: Transforming Pharma R&D and Commercial Strategy 30
4.1 The role of mHealth Technologies in the Pharmaceutical Industry 30
4.1.1 What Specific Opportunities do mHealth Solutions Represent for Pharma Companies? Results from our Industry-Wide Survey 30
4.2 In Which Specific Areas Do Organizations Currently Utilize mHealth Technology? Results from our Industry-Wide Survey 32
4.2.1 Linking Early Research with Patient Data through Mobile Solutions 33
4.2.2 Will mHealth Technologies Solve the Patient Recruitment Bottleneck in Clinical Trials? 34
4.2.3 Improving Patient Compliance, Retention and Monitoring in Clinical Trials Through mHealth Solutions 35
4.2.4 How Will mHealth Solutions Improve Health Economic Analysis and Payer Engagement? 37
4.2.5 mHealth Opportunities for the Pharmaceutical Industry Beyond R&D 38
4.3 In Which Areas Will mHealth Have the Greatest Impact for Pharma Companies Over the Next Five Years? Results from our Industry-Wide Survey 41
5 The Most Promising Geographical Markets for mHealth Technologies in 2017 43
5.1 Important Trends in Mobile Penetration at a Global Level and Their Impact in Key mHealth Markets 43
5.2 Will Emerging Economies Continue to Be the Primary Drivers of Growth in the mHealth Market? 43
5.2.1 Which Emerging Economy Will Represent the Highest Revenue-Generating Market for mHealth Solutions and Services Over the Next Five Years? Results from our Industry-Wide Survey 44
5.2.2 Opportunities and Challenges in the Chinese mHealth Market in 2017 45
5.2.3 Opportunities and Challenges in the Indian mHealth Market in 2017 45
5.2.4 Opportunities and Challenges in the South Korean mHealth Market in 2017 46
5.2.5 Opportunities and Challenges in the Brazilian mHealth Market in 2017 46
5.2.6 Barriers to mHealth Implementation in Emerging Economies 46
6 Strategic Considerations for Effective Implementation of mHealth Initiatives 48
6.1 What Are the Most Important Factors to Consider when Designing a New mHealth Initiative? Results from our Industry-Wide Survey 48
6.1.1 Understanding Consumer Trends for New mHealth Initiatives 49
6.1.2 Considering Technological Trends for New mHealth Initiatives 49
6.1.3 Macroeconomic Trends Important for mHealth Initiatives 49
6.1.4 Security and Intellectual Property Considerations for mHealth Initiatives 49
6.1.5 Deploying an Effective Marketing Strategy for mHealth Initiatives 50
6.1.6 Channel Analysis for mHealth Initiatives 50
6.2 Other Important Considerations for Companies Designing mHealth Initiatives 51
Table 1: eHealth: Key Branches and Descriptions 8
Table 2: Examples of Important mHealth Services Currently Available 9
Table 3: FDA Guidance on Mobile Medical Applications by Subset 25
Table 4: Pharmaceutical mHealth Solutions Supporting Marketing and Patient Educational Efforts 39
Table 5: mHealth Solutions Supporting Drug Anti-counterfeiting Efforts 40
Table 6: mHealth Solutions Supporting Pharmaceutical Post-Marketing Surveillance Efforts 40
Table 7: Smartphone Penetration Rates in Key Geographical Markets (%), 2016 and 2020 44
Table 8: Important Considerations and Recommendations For Companies Designing mHealth Initiatives 51
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017